Restructuring, Impairments, and Related Charges	12 Months Ended
Jun. 30, 2023
Restructuring and Related Activities [Abstract]
Restructuring, Impairments, and Related Charges	15. Restructuring, Impairments, and Related Charges The Company did not have any restructuring liability as of June 30, 2023 and 2022. As of June 30, 2021, the restructuring liability was $0.3 million, which was recorded in “Other accrued liabilities” in the accompanying consolidated balance sheet. During fiscal years ended June 30, 2023, 2022 and 2021, the Company recorded restructuring, impairment and related charges of $2.9 million, $1.7 million and $2.6 million, respectively. The charges are reflected in “Restructuring and related charges” in the consolidated statements of operations. 2023 Restructuring During fiscal 2023, the Company initiated a restructuring plan to transform our business infrastructure and reduce our facilities footprint and the facilities related charges (the “2023 Plan”). As part of this project the Company will move engineering labs from its San Jose, California location to its Salem, New Hampshire location. This move is expected to help reduce the cost of operating our labs. The Company expects that the project will take about 18 to 24 months for completion and expects to incur charges of approximately $10.0 million throughout this period primarily for asset disposals, contractor costs, severance, relocation and other non-recurring fees. 2022 Restructuring During fiscal 2022, the Company recorded $1.7 million of restructuring charges which was primarily consisted of facility related charges. The facility restructuring charges included some impairment charges and additional facilities expenses related to previously impaired facilities. In addition, during fiscal 2022, the Company completed the reduction-in-force action initiated in the third quarter of fiscal 2020 to reduce its operating costs and enhance financial flexibility (the “2020 Plan”). The Company had incurred $9.6 million of charges under the 2020 Plan through June 30, 2022. 2021 Restructuring During fiscal 2021, the Company continued its cost reduction initiative begun in the third quarter of fiscal 2020 and recorded related severance, benefits, and equipment relocation charges of $1.5 million, related to the 2020 Plan. In addition, the Company incurred facility-related charges of $1.1 million, which represented additional expenses related to previously impaired facilities. Severance and benefits charges consisted primarily of additional employee severance and benefit expenses incurred under the 2020 Plan. With the reduction and realignment of the headcount under the 2020 Plan, the Company relocated certain of its lab equipment to third-party consulting companies. The Company had incurred $9.6 million of charges under the 2020 Plan through June 30, 2021.

Restructuring, Impairments, and Related Charges

12 Months Ended

Jun. 30, 2023

Restructuring and Related Activities [Abstract]

Restructuring, Impairments, and Related Charges

15. Restructuring, Impairments, and Related Charges

The Company did not have any restructuring liability as of June 30, 2023 and 2022. As of June 30, 2021, the restructuring liability was $0.3 million, which was recorded in “Other accrued liabilities” in the accompanying consolidated balance sheet.

During fiscal years ended June 30, 2023, 2022 and 2021, the Company recorded restructuring, impairment and related charges of $2.9 million, $1.7 million and $2.6 million, respectively. The charges are reflected in “Restructuring and related charges” in the consolidated statements of operations.

2023 Restructuring

During fiscal 2023, the Company initiated a restructuring plan to transform our business infrastructure and reduce our facilities footprint and the facilities related charges (the “2023 Plan”). As part of this project the Company will move engineering labs from its San Jose, California location to its Salem, New Hampshire location. This move is expected to help reduce the cost of operating our labs. The Company expects that the project will take about 18 to 24 months for completion and expects to incur charges of approximately $10.0 million throughout this period primarily for asset disposals, contractor costs, severance, relocation and other non-recurring fees.

2022 Restructuring

During fiscal 2022, the Company recorded $1.7 million of restructuring charges which was primarily consisted of facility related charges. The facility restructuring charges included some impairment charges and additional facilities expenses related to previously impaired facilities. In addition, during fiscal 2022, the Company completed the reduction-in-force action initiated in the third quarter of fiscal 2020 to reduce its operating costs and enhance financial flexibility (the “2020 Plan”). The Company had incurred $9.6 million of charges under the 2020 Plan through June 30, 2022.

2021 Restructuring

During fiscal 2021, the Company continued its cost reduction initiative begun in the third quarter of fiscal 2020 and recorded related severance, benefits, and equipment relocation charges of $1.5 million, related to the 2020 Plan. In addition, the Company incurred facility-related charges of $1.1 million, which represented additional expenses related to previously impaired facilities. Severance and benefits charges consisted primarily of additional employee severance and benefit expenses incurred under the 2020 Plan. With the reduction and realignment of the headcount under the 2020 Plan, the Company relocated certain of its lab equipment to third-party consulting companies. The Company had incurred $9.6 million of charges under the 2020 Plan through June 30, 2021.